» Articles » PMID: 2404871

Characterization of Anti-core Glycolipid Monoclonal Antibodies with Chemically Defined Lipopolysaccharides

Overview
Journal Infect Immun
Date 1990 Feb 1
PMID 2404871
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Five anti-core glycolipid monoclonal antibodies (MAb) (four against Escherichia coli J5 lipopolysaccharide [LPS] and one against the Re core glycolipid of Salmonella typhimurium) were characterized using LPS from several rough and smooth strains and derivatives of E. coli J5 LPS, obtained by N acetylation and hydrolysis. The MAb against E. coli J5 were not only weakly cross-reactive with clinical isolates, whereas the anti-Re MAb was highly cross-reactive. The MAb differed in their reaction pattern with E. coli J5 LPS. MAb 4-7B5 (immunoglobulin M) and MAb 4-6A1 (immunoglobulin G1) cross-reacted with LPS of Salmonella minnesota R5 and S. typhimurium Ra and Rc and little with Re and lipid A. The dominant binding site of these MAb was located in the glucose-heptose-heptose region and was independent of phosphate substitution. The MAb 4-9A1 reacted with the terminal part of the core region (glucose-heptose) and was dependent on phosphate substitution of the LPS. The MAb BA7 (immunoglobulin G3) was E. coli J5 LPS specific and reacted with the glucosaminyl-heptose disaccharide. Antibody 8-2C1 was directed against the common parts of LPS, 3-deoxy-D-manno-octulosonic acid, and lipid A, which are not (or only weakly) recognized by the four anti-J5 LPS MAb. Thus, MAb that are not cross-reactive can be directed against at least three different antigenic determinants present on the core oligosaccharide of E. coli J5 LPS.

Citing Articles

Development, characterization, and biological properties of meningococcal immunotype L3,7,(8),9-specific monoclonal antibodies.

Verheul A, Kuipers A, Braat A, Dekker H, Peeters C, Snippe H Clin Diagn Lab Immunol. 1994; 1(6):729-36.

PMID: 8556528 PMC: 368403. DOI: 10.1128/cdli.1.6.729-736.1994.


Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritidis as measured with luminol-enhanced chemiluminescence.

Wagner D, Heinrich D Infect Immun. 1994; 62(10):4320-4.

PMID: 7927690 PMC: 303111. DOI: 10.1128/iai.62.10.4320-4324.1994.


Immunoprophylaxis and immunotherapy of gram-negative sepsis and shock with antibodies to core glycolipids and lipid A of bacterial lipopolysaccharides.

Mitov I, Terziiski D Infection. 1991; 19(6):383-90.

PMID: 1816107 DOI: 10.1007/BF01726444.


Infectious disease therapy in the 1990s. Where are we heading?.

Rozenberg-Arska M, Visser M Drugs. 1992; 43(5):629-36.

PMID: 1379143 DOI: 10.2165/00003495-199243050-00001.

References
1.
Brade H, Galanos C . A method to detect 2-keto-3-deoxyoctanat and related compounds on pherograms and chromatograms. Anal Biochem. 1983; 132(1):158-9. DOI: 10.1016/0003-2697(83)90440-2. View

2.
Ziegler E, McCutchan J, Fierer J, Glauser M, Sadoff J, Douglas H . Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med. 1982; 307(20):1225-30. DOI: 10.1056/NEJM198211113072001. View

3.
Nelles M, Niswander C . Mouse monoclonal antibodies reactive with J5 lipopolysaccharide exhibit extensive serological cross-reactivity with a variety of gram-negative bacteria. Infect Immun. 1984; 46(3):677-81. PMC: 261596. DOI: 10.1128/iai.46.3.677-681.1984. View

4.
Teng N, Kaplan H, Hebert J, Moore C, Douglas H, Wunderlich A . Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci U S A. 1985; 82(6):1790-4. PMC: 397358. DOI: 10.1073/pnas.82.6.1790. View

5.
Gigliotti F, Shenep J . Failure of monoclonal antibodies to core glycolipid to bind intact smooth strains of Escherichia coli. J Infect Dis. 1985; 151(6):1005-11. DOI: 10.1093/infdis/151.6.1005. View